Mobile Menu - OpenMobile Menu - Closed

Hearing on "ARPA-H: The Next Frontier of Biomedical Research"

Date: 
Tuesday, February 8, 2022 - 10:30am
Location: 
Hybrid Hearing in the John D. Dingell Room, 2123 of the Rayburn House Office Building, and Cisco Webex

The Subcommittee on Health of the Committee on Energy and Commerce held a hybrid hearing that included both in-person and remote attendance on Tuesday, February 8, 2022, at 10:30 a.m. This hearing took place in the John D. Dingell Room, 2123 of the Rayburn House Office Buidling, as well as remotely using Cisco Webex online video conferencing. The hearing is entitled, "ARPA-H: The Next Frontier of Biomedical Research."

 

Key Documents

Memorandum from Chairman Pallone to the Subcommittee on Health 

Opening Statement from Chairman Pallone as prepared for delivery

Opening Statement from Subcommittee Chairwoman Eshoo as prepared for delivery

 

Livestream

 

Witnesses

Keith R. Yamamoto, Ph.D.
Vice Chancellor for Science Policy and Strategy
University of California San Francisco

Testimony

 

Esther Krofah
Executive Director
FasterCures and Center for Public Health at the Milken Institute

Testimony

 

Geoffrey Shiu Fei Ling, M.D., Ph.D.
CEO, On Demand Pharmaceuticals
Professor of Neurology, Johns Hopkins Medicine

Testimony

Supplement #1

 

Admiral Brett P. Giroir
Former Assistant Secretary for Health
U.S. Department of Health and Human Services

Testimony

 

Brian James Miller, M.D., M.B.A., M.P.H.
Professor of Medicine
John Hopkins Medicine

Testimony

 

Issues: